This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

An Affect Management Intervention for Juvenile Offenders

This study has been completed.
Information provided by:
Rhode Island Hospital Identifier:
First received: September 5, 2008
Last updated: February 5, 2009
Last verified: February 2009
Adolescents are at risk for HIV because of sexual and drug behavior initiated during this developmental period. Adolescents in the juvenile justice system are at increased risk for HIV due to higher rates of substance use and psychopathology than their non-offending peers. Juvenile justice youth may therefore also be less likely to benefit from frequently used skills based interventions. It appears that emotional lability, frequently found in this population, disrupts skills learned. This project will implement and evaluate an affect management HIV prevention intervention for adolescents in a juvenile drug court program. Affect management and general health promotion interventions will be compared to determine which intervention best reduces risk behavior among adolescents in the drug court.

Condition Intervention Phase
HIV Infections Behavioral: Affect Management Behavioral: General Health Promotion Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: An Affect Management Intervention for Juvenile Offenders

Resource links provided by NLM:

Further study details as provided by Rhode Island Hospital:

Primary Outcome Measures:
  • Adolescent-reported sexual activity and condom use [ Time Frame: 3 month post-intervention ]

Secondary Outcome Measures:
  • Adolescent substance use (self-report and urine toxicology screen results) [ Time Frame: 3 months post-intervention ]

Enrollment: 95
Study Start Date: September 2004
Study Completion Date: October 2007
Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Behavioral: Affect Management
5 session group intervention that focused on teaching affect management skills and included HIV prevention and sexual health training
Active Comparator: 2 Behavioral: General Health Promotion
5 session group focused on delivering general health promotion information in didactic format


Ages Eligible for Study:   13 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Adolescents enrolled in the juvenile drug court program

Exclusion Criteria:

  • Adolescent is HIV positive
  • Adolescent is pregnant
  • Adolescent is developmentally delayed
  • Adolescent has history of sexual crime
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00748800

United States, Rhode Island
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
Sponsors and Collaborators
Rhode Island Hospital
Principal Investigator: Larry K Brown, MD Rhode Island Hospital
  More Information

Responsible Party: Larry K. Brown, M.D./Principal Investigator, Rhode Island Hospital Identifier: NCT00748800     History of Changes
Other Study ID Numbers: R21DA019245 ( U.S. NIH Grant/Contract )
Study First Received: September 5, 2008
Last Updated: February 5, 2009

Keywords provided by Rhode Island Hospital:
HIV prevention
HIV seronegativity

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on September 21, 2017